US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
SI1318997T1
(sl)
*
|
2000-09-15 |
2006-12-31 |
Vertex Pharma |
Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
ZA200301703B
(en)
*
|
2000-09-15 |
2004-03-02 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors.
|
NZ525008A
(en)
*
|
2000-09-15 |
2004-12-24 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
MXPA03005605A
(es)
*
|
2000-12-21 |
2003-10-06 |
Vertex Pharma |
Compuestos de pirazol utiles como inhibidores de la proteina cinasa.
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
MXPA04001114A
(es)
|
2001-09-26 |
2004-05-20 |
Pharmacia Italia Spa |
Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
|
WO2003066629A2
(en)
*
|
2002-02-06 |
2003-08-14 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds useful as inhibitors of gsk-3
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
EP1506176B1
(en)
|
2002-05-17 |
2013-04-24 |
Pfizer Italia S.r.l. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
ES2273043T3
(es)
|
2002-08-02 |
2007-05-01 |
Vertex Pharmaceuticals Incorporated |
Composiciones de pirazol utiles como inhibidores de gsk-3.
|
CA2502429A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Antiinflammation agents
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
CN1902193B
(zh)
*
|
2003-12-04 |
2011-07-13 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的喹喔啉
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
WO2007022384A2
(en)
|
2005-08-18 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
CN103145702A
(zh)
*
|
2005-11-03 |
2013-06-12 |
顶点医药品公司 |
用作激酶抑制剂的氨基嘧啶
|
BRPI0709963A2
(pt)
*
|
2006-04-14 |
2011-08-02 |
Abbott Lab |
processo para a preparação de indazolil uréias que inibem receptores de subtipo 1 de vanilóide (vr1)
|
CA2668429A1
(en)
|
2006-11-02 |
2008-05-15 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
ES2347721T3
(es)
|
2006-12-19 |
2010-11-03 |
Vertex Pharmaceuticals, Inc. |
Aminopirimidinas utiles como inhibidores de proteina quinasas.
|
MX2009009592A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopiridinas utiles como inhibidores de proteinas cinasas.
|
CA2679884A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
WO2008112651A2
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
CN101679386A
(zh)
|
2007-04-13 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
NZ580884A
(en)
*
|
2007-05-02 |
2012-02-24 |
Vertex Pharma |
Thiazoles and pyrazoles useful as kinase inhibitors
|
JP5389786B2
(ja)
|
2007-05-02 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害として有用なアミノピリミジン
|
MX2009012719A
(es)
*
|
2007-05-24 |
2010-02-04 |
Vertex Pharma |
Tiazoles y pirazoles utiles como inhibidores de cinasa.
|
AU2008282156B2
(en)
|
2007-07-31 |
2014-07-17 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
JP2012501971A
(ja)
*
|
2008-09-03 |
2012-01-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶および共結晶を含む薬学的処方物
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
BR112015001546B1
(pt)
|
2012-07-24 |
2021-02-23 |
Bial-Portela & Ca, S.A |
compostos de ureia e sua utilização como inibidores enzimáticos
|
US20150197503A1
(en)
*
|
2012-07-27 |
2015-07-16 |
Bial-Portela & Cª, S.A. |
Process for the synthesis of substituted urea compounds
|
CA2918993C
(en)
|
2013-07-24 |
2021-08-24 |
Bial - Portela & Ca, S.A. |
Imidazolecarboxamides and their use as faah inhibitors
|